Hybio Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year of 2015; Announces Management Changes
The company also approved the resignation of Yu Xiufeng as independent director, and elected Cao Dieyun as independent director.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.77 CNY | -0.08% |
|
+9.69% | -13.33% |
29/05 | 3SBIO Unit to Cooperate on Development, Sale of Weight Management Injection | MT |
29/05 | Hybio Pharmaceutical Grants Commercial Rights of Weight Loss Drug to Sansheng Mandi Pharmaceutical | MT |
1st Jan change | Capi. | |
---|---|---|
-13.33% | 143.37Cr | |
+16.80% | 4.33TCr | |
+22.16% | 2.16TCr | |
+21.73% | 1.59TCr | |
+23.95% | 1.51TCr | |
+57.96% | 1.3TCr | |
-0.05% | 678.76Cr | |
-14.88% | 629.03Cr | |
+21.38% | 603.62Cr | |
-8.87% | 572.55Cr |